Dolby Laboratories (DLB) Teams Up With Apple For Formula 1, Is The Stock Still Undervalued?
Dolby Laboratories (DLB) is back in focus after announcing that Dolby Atmos will feature in Formula 1 coverage on Apple TV starting with the 2026 U.S. Grand Prix, alongside existing Dolby Vision support.
Recent trading suggests investors are warming to Dolby Laboratories again, with a 90 day share price return of 23.97% and a 7 day share price gain of 4.07% lifting the stock to US$60.83. This comes even though the year to date share price return is down 4.25% and the 1 year total shareholder return has declined 8.72%. The longer term 3 and 5 year total shareholder returns are weaker, at declines of 20.09% and 28.54% respectively, as the market reassesses the business after high profile content partnerships such as the new Formula 1 deal on Apple TV.
Scan beyond Dolby Laboratories and see which other audio tech and media software players are getting attention in the 20 high quality undiscovered gems.
After a sharp run back to US$60.83, the Dolby Laboratories rebound still looks like a warm up rather than a finished race. How much of the potential upside remains once the valuation is on the table?
Most Popular Narrative: 23% Undervalued
Against a last close of $60.83, the most followed Dolby Laboratories narrative anchors fair value at $79. This frames the latest rally as only a partial catch up rather than a full rerating.
Expanding Dolby Laboratories licensing beyond device OEMs into content and usage based models through the video distribution patent program is adding new royalty streams from major global streaming platforms, which can deepen revenue and support earnings over time.
See why 16 investors see Dolby Laboratories as 23% undervalued.
Result: Fair Value of $79 (UNDERVALUED)
Still, the bullish Dolby Laboratories story can be knocked off course if elevated component costs keep pressuring low end devices, or if newer content focused projects fail to earn back their spending.
Find out about the key risks to this Dolby Laboratories narrative.
Another View: What Multiples Say About Dolby Laboratories
The story changes once the focus shifts from fair value models to plain earnings multiples. Dolby Laboratories trades on a P/E of 25.2x, which is slightly higher than its own fair ratio of 24.6x but lower than the US Software average at 30.7x and the peer group at 38.7x.
That mix of a slightly above-fair ratio yet a lower level than the wider sector points to both valuation risk and the potential for the multiple to narrow relative to peers. If the multiple moves closer to the fair ratio rather than to peer levels, an important question is whether the recent share price rebound would still appear attractive to new buyers.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals around Dolby Laboratories can create plenty of noise, so move quickly, review the underlying data, and weigh the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Dolby Laboratories?
If Dolby Laboratories has sharpened your focus, you may wish to widen the lens and use the Simply Wall Street Screener to explore other opportunities before the crowd catches up.
- Target potential value opportunities early by scanning a curated set of quality stocks that screen as attractively priced through the 32 high quality undervalued stocks.
- Prioritise resilience by filtering for businesses with stronger finances using the list of solid balance sheet and fundamentals (25 results) to help avoid fragile balance sheets.
- Protect against sleepless nights by using the 32 resilient stocks with low risk scores to focus on companies with more measured risk profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com